We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+16.2%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$6.6B
AUM Growth
+$430M
Cap. Flow
+$25.1M
Cap. Flow %
0.38%
Top 10 Hldgs %
17.96%
Holding
434
New
82
Increased
115
Reduced
129
Closed
91

Top Buys

Rank Stock Value
1
CALX icon
Calix
CALX
+$48.2M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$44.8M
3
WING icon
Wingstop
WING
+$42.6M
4
EPAM icon
EPAM Systems
EPAM
+$40M
5
RBA icon
RB Global
RBA
+$38.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$75.3M
2
FIVN icon
FIVE9
FIVN
+$40.4M
3
AIR icon
AAR Corp
AIR
+$34.3M
4
DOCN icon
DigitalOcean
DOCN
+$32.2M
5
XPEV icon
XPeng
XPEV
+$30.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.47%
2 Technology 20.32%
3 Industrials 15.76%
4 Consumer Discretionary 10.97%
5 Consumer Staples 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECOM
426
DELISTED
CHANNELADVISOR CORPORATION
ECOM
-594,049
Closed -$8.66M
AVLR
427
DELISTED
Avalara, Inc.
AVLR
-99,096
Closed -$7M
IEA
428
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-342,499
Closed -$2.75M
GBT
429
DELISTED
Global Blood Therapeutics, Inc.
GBT
-805,861
Closed -$25.7M
SAIL
430
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
-116,372
Closed -$7.29M
HZNP
431
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-82,150
Closed -$6.55M
EGLE
432
DELISTED
Eagle Bulk Shipping Inc.
EGLE
-58,423
Closed -$3.03M
BHVN
433
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-50,830
Closed -$7.41M

Similar funds

Driehaus Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Driehaus Capital Management held 434 positions worth $6.6B, up 7% from $6.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Driehaus Capital Management's Q3 2022 filing shows 82 new, 115 increased, 129 reduced and 91 closed positions. Its largest new stake was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M. The largest sale was Pfizer, an estimated $75.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Driehaus Capital Management's largest Q3 2022 buy was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M.
  • Driehaus Capital Management added most to Calix in Q3 2022, an estimated $48.2M increase.
  • Driehaus Capital Management's biggest Q3 2022 reduction was HDFC Bank, cutting an estimated $30M.
  • Driehaus Capital Management fully exited Pfizer in Q3 2022, selling an estimated $75.3M.
  • Driehaus Capital Management's ten largest holdings make up 18% of its $6.6B portfolio in Q3 2022.
  • Driehaus Capital Management opened 82 new positions and closed 91 in Q3 2022.
  • Driehaus Capital Management's portfolio value rose 7% quarter-over-quarter to $6.6B.

Based on Driehaus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.